Skip to content
banner-news_01

Group News

  • Aspen presented with prestigious SAIC Business Award
    on 25.03.2022

    Aspen was presented with the prestigious South African Investment Conference Business Award which recognised Companies that best responded to the challenges of the COVID environment. Johannesburg, South Africa - Aspen Pharmacare, a global specialty and branded pharmaceutical company was honoured at the 4th South African Investment Conference (“SAIC”) when it was presented with an award, by South African […]

  • Aspen announces R500 million investment at 4th SAIC
    on 24.03.2022

    Johannesburg, South Africa - Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha.   The announcement comes in the wake of more than R8 billion […]

  • Aspen donates life-saving medicines for 62000 surgeries in Ukraine
    on 23.03.2022

    Aspen has donated life saving medicines valued at R11 million to facilitate 62 000 surgeries in Ukraine Johannesburg, South Africa - Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further […]

  • Aspen helps evacuate SA students stranded in the Ukraine
    on 10.03.2022

    Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Aspen partnered with the the South African Department of International Relations and Cooperation to repatriate students from the Ukraine Johannesburg, South Africa - Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International […]

  • Aspen delivers double digit organic revenue grown in constant exchange rates
    on 09.03.2022

      Johannesburg - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2021. SALIENT RESULTS Aspen reported the following salient results: Revenue from continuing operations increased by 4% (+10% in constant exchange rate (“CER”) to R19,4 billion (December […]

Scroll To Top